| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
UMR Centre National de la Recherche Scientifique 5123, Physiologie des Régulations Energétiques, Cellulaires et Moléculaires, Université Lyon I, Campus La Doua, 69622 Villeurbanne, France
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Recent studies indicate that regression of left ventricular hypertrophy normalizes membrane ionic current abnormalities. This work was designed to determine whether regression of right ventricular hypertrophy induced by permanent high-altitude exposure (4,500 m, 20 days) in adult rats also normalizes changes of ventricular myocyte electrophysiology. According to the current data, prolonged action potential, decreased transient outward current density, and increased inward sodium/calcium exchange current density normalized 20 days after the end of altitude exposure, whereas right ventricular hypertrophy evidenced by both the right ventricular weight-to-heart weight ratio and the right ventricular free wall thickness measurement normalized 40 days after the end of altitude exposure. This morphological normalization occurred at both the level of muscular tissue, as shown by the decrease toward control values of some myocyte parameters (perimeter, capacitance, and width), and the level of the interstitial collagenous connective tissue. In the chronic high-altitude hypoxia model, the regression of right ventricular hypertrophy would not be a prerequisite for normalization of ventricular electrophysiological abnormalities.
hypertrophy; right ventricular myocytes; fibrosis; action potential; ionic currents
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
RECENT EVIDENCE in animal models of left ventricular (LV) hypertrophy (LVH) suggests that LVH regression is associated with normalization of ventricular electrophysiology (18, 19, 28). Chronic hypoxia is the main pathophysiological factor in severe disturbances of the cardiovascular system, represented by pulmonary, ischemic, and congenital heart disease and in cardiopulmonary changes induced by exposure to a high-altitude environment (17). Development of right ventricular (RV) hypertrophy (RVH) is a common consequence of increased pulmonary vascular resistance in most mammals (including humans) living at high altitudes (25). This phenomenon also occurs in experimental animal models during exposure to either normobaric or hypobaric high-altitude hypoxia simulated under laboratory conditions (21). One of the most typical characteristics of phenotypical adaptations is their reversible nature. It has been shown that even severe chronic hypoxia-induced changes, such as pulmonary hypertension and RVH, are completely reversible after removal of the animals from the hypoxic atmosphere for a sufficiently long period of time (15). Recently, we demonstrated that chronic hypobaric high-altitude hypoxia induced true RV myocyte hypertrophy in rats and that hypertrophied cells showed prolongation of their action potential duration (APD) compared with control cells (4, 5). Moreover, we showed that the decrease of the transient outward current (Ito1) and the increase of the Na/Ca exchange current (INa/Ca) densities might account for the lengthening of the action potential (4, 7). However, no data are available about the reversibility of the electrophysiological changes, especially membrane current changes, during the course of RVH regression.
In the present study, we examined the reversibility of morphological and electrophysiological changes induced by chronic high-altitude hypoxia in the adult rat heart when the animals were returned to normoxic conditions. The results show a differential normalization of electrophysiological and morphological changes; the normalization of electrophysiological changes occurs before the normalization of morphological changes.
| |
MATERIALS AND METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Animal Model
RVH was induced in adult male Sprague-Dawley rats weighing 350-400 g (11 wk old upon delivery from the breeder, Iffa Credo; L'Arbresle, France) as previously described (4, 5). Briefly, rats were placed for 20 days in a hypobaric chamber, allowing exposure to a simulated altitude (
4,500 m;
PO212 kPa). Control rats were maintained
under normoxic conditions. Chronic congestive heart failure never
occurred in this model. This was confirmed by anatomic examination
(n = 187), which did not show the presence of pleural
fluid, hepatic congestion, and ascites, which are criteria of failure
in RVH (23). Animals in both groups had free access to
food and water. The regression of hypertrophy was assessed 20 and 40 days after the end of hypoxic exposure, which was assigned day
0. Data obtained from the exposed group were compared with those
of age-matched control group.
Histological Studies
Heart extraction, perfusion, and chemical treatment. Animals were anesthetized with pentobarbital. The heart was excised and immersed in ice-cold Ca-free Tyrode solution. The aorta was cannulated, and a retrograde perfusion was performed, first with Ca-free Tyrode solution at 37°C for 5-10 min and then with fixative solution (0.5% paraformaldehyde and 1% glutaraldehyde in 0.1 M cacodylate buffer; pH 7.4) for 1 h. After fixation, the heart was transversally cut from the atrioventricular level to the ventricular top into 2-mm-thick slices with a vibratome. Slices were overfixed overnight in fixative solution, washed in buffer, osmium postfixed (0.25% in buffer), dehydrated, and embedded in a methacrylate histological resin. The morphometric study was made from an identical slice level for each heart. From the 2-mm-thick slices, thin 5-µm sections were realized.
Ventricular wall thickness measurements. Morphometric analysis was performed both on thick and thin sections, the latter being stained with toluidine blue. Each of them were macrophotographed. On uniformly magnified printings, ventricular walls were manually outlined. Image analysis and quantification were then performed with a Leica image analyzer (Performance Q 5001 W). After calibration, the RV wall, LV wall, and septum surfaces were manually outlined on the screen, and their surfaces were automatically deduced.
Myocyte size and total collagenic mass measurements.
The ventricular transversal sections present multiple cardiomyocyte
orientations, but for the reliability of measurements we always
selected the large tranversal cellular fields of trabecules protruding in the ventricular luminae (Fig.
1). The Gordon Sweet silver staining
method was used to underscore the total collagenic mass: black staining
for collagen 3 and 4 and maroon for collagen 1, both of them being
equally detected and compiled by the camera for image analysis. This
allowed us to 1) very precisely outline the cardiomyocyte
transversal sections for comparison of cell circumferences in control
and treated samples and 2) make an overall analysis of the
extracellular fibrous elements to evaluate the effects of hypertrophy
on the collagenic mass.
|
Heart Weight Measurements and Myocyte Isolation
These procedures were made as previously described (4, 5). The dimensions of freshly dissociated myocytes was assessed by measuring length and width with a graticule mounted on the lens of a microscope.Electrophysiological Techniques and Solutions
The electrophysiological experiments were carried out at room temperature (20-23°C) on isolated RV cells with the conventional whole cell patch-clamp method in current-clamp or in voltage-clamp conditions (8). Pipettes with a 1- to 3-M
resistance
were routinely used and connected to the headstage of a RK400 amplifier (Biologic; Grenoble, France) with a 100-M feedback resistor. Cells
were placed in a plastic petri dish containing the appropriate extracellular medium (see below); the cell from which the recording was
being made was continuously superfused with solutions flowing by
gravity from a set of five capillaries located near the cell and
allowing rapid changes (within 5 s) of the extracellular medium. The superfusion flow rate was 20-40 µl/s.
Membrane capacitance was systematically measured and calculated by analyzing the capacitive surge produced by a small voltage step as described previously (4).
The series resistance (Rs) ranged from 4 to 5 M when filled with the internal solution (see below). Membrane
capacitance and Rs were not compensated. Because
of the presence of Rs, the membrane potential
(Vm) deviates from the command potential
(Vc) according to the following equation:
Vm = Vc[1 
(Rs/Rs + Rm)], where
Rs/(Rs + Rm) is the error factor. From the slope
of the Ito1-voltage relationships, we determined
Rs + Rm, which gives a good estimate of the lowest Rm value. The
maximal error factor was estimated to be 0.24 ± 0.03 and
0.23 ± 0.03 (n = 19 in each group;
P = 0.81) during the flow of
Ito1 in the control day 0 group and
in the regression day 0 group, respectively (see
RESULTS for a more detailed description of these groups).
Note that the difference between the error factors of the two groups is
not significant and thus should not affect the comparison between them.
Action potentials were elicited by a 5-ms depolarizing current pulse at
a rate of 0.2 Hz and sampled at 1 kHz. Voltage-clamp protocols are
described in RESULTS. Current traces were sampled at 5 kHz
and uncorrected for the leak. Current or voltage commands and
simultaneous signal recordings used pCLAMP software (Axon Instruments).
For action potential recording, the internal solution in the patch electrode contained (in mM) 7 NaCl, 110 potassium aspartate, 30 KCl, 2 MgCl2, 10 glucose, 0.2 EGTA/KOH, and 5 HEPES/KOH (pH = 7.2), and the external solution contained (in mM) 140 NaCl, 5 KCl, 2 MgCl2, 2.5 CaCl2, 10 glucose, and 10 HEPES/NaOH (pH = 7.4).
For the Ito1 recording, the internal solution in the patch electrode contained (in mM) 130 potassium aspartate, 5 KCl, 5 MgCl2, 10 glucose, 3 K2-ATP, 5 Na2-CP, 0.4 Na3-GTP, 5 EGTA/KOH, and 10 HEPES/KOH (pH = 7.2), and the external solution contained (in mM) 135 choline-Cl, 1.1 MgCl2, 2.5 CaCl2, 0.5 CdCl2, 10 glucose, 0.01 atropine sulfate, and 10 HEPES/KOH (pH = 7.4).
For the INa/Ca recording, the internal solution in the patch electrode contained (in mM) 7 NaCl, 20 CsCl, 110 cesium aspartate, 1.1 MgCl2, 0.2 EGTA/CsOH, and 5 HEPES/CsOH (pH = 7.2), and the external solution contained (in mM) 140 NaCl or LiCl, 5 CsCl, 2 MgCl2, 2.5 CaCl2, 10 glucose, and 5 HEPES/NaOH or LiOH (pH = 7.4).
Osmolarity was between 300 and 320 mosM for every solution.
Statistical Analysis
All values are expressed as means ± SE; n = number of experiments. The statistical significance of differences between groups was determined by a nonparametric Mann-Whitney test. A difference was assumed to be statistically significant when P < 0.05. Selection of representative records was based on close similarity of their APD or the amplitude of the current density to mean values.| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Morphometric Changes
Figure 2 shows the evolution of the RV mass of control and altitude-exposed rats (Reg rats) at 0, 20, and 40 days after the end of hypoxic exposure. To isolate the regression phenomenon, differences (expressed in percentages) can be considered between exposed and control rats. At day 0, this difference for the RV weight-to-heart weight ratio (Fig. 2A) was 40% and only 18% and 7% at 20 and 40 days of regression, respectively. Figure 2B shows the representative change in macroscopic morphology of the heart from a control day 0 rat (a) and from Reg day 0 (b), Reg day 20 (c), and Reg day 40 rats (d). The thickness of the RV free wall in Reg day 0 and Reg day 20 rats was markedly increased, whereas the LV and septal wall thicknesses were unaffected. The difference for the RV wall thickness (Fig. 2C) between exposed and control rats was 62.1%, 57.8%, and 12% at 0, 20, and 40 days of regression, respectively.
|
Figure 3 shows the evolution of some RV
myocyte parameters. The difference for the myocyte size (Fig.
3A) between exposed and control rats was 10.6%, 5.9%, and
3.2% at 0, 20, and 40 days of regression, respectively. For the
myocyte capacitance (Fig. 3B), this difference was 50.8%,
23.6%, and 13.9% at 0, 20, and 40 days of regression, respectively,
whereas for myocyte width (Fig. 3C), it was 35.4%, 27.2%,
and 3.9% at 0, 20, and 40 days of regression, respectively.
|
Figure 4C shows the evolution
of pericellular fibrosis (see MATERIALS AND METHODS). The
difference between exposed and control rats was 25.6%, 17.4%, and
0.6% at 0, 20, and 40 days of regression, respectively.
|
It is noteworthy that for all the morphometric parameters measured, the differences between exposed and control rats were no longer significant at 40 days after the end of hypoxic exposure.
Action Potential Changes
Typical action potential recordings in control and in Reg RV myocytes are illustrated in Fig. 5, A-C. There were no significant differences in resting membrane potential or action potential amplitude among the three groups or between the individual groups nor in the APD of control myocytes between the three groups except between control APD at 25% repolarization (APD25) at day 0 and at day 40 (Fig. 5D). This latter result is qualitatively similar to those reported previously in the rat atrium and attributed to an age-dependent prolongation (3). The marked difference in APD between control and Reg rats at day 0 was no longer recorded 20 days after the end of hypoxic exposure (Fig. 5D). Indeed, this difference measured at 90% of repolarization was 219.2%, 8.5%, and 9.8% at 0, 20, and 40 days of regression, respectively.
|
Ito1 and INa/Ca Changes
Figure 6, A-C, shows representative Ito1 recordings elicited by a step depolarization to +30 mV from a holding potential of80 mV in
control and Reg RV myocytes. Ito1 was evaluated
as the difference between peak current and the current at the end of the 600-ms pulse. As previously shown (4), significant
differences in mean Ito1 densities between
control and Reg myocytes were observed only at day 0 between
+10 and +60 mV (Fig. 6D). For instance, at +30 mV, the
difference was 43.9%, 22.2%, and 5.8% at 0, 20, and 40 days of
regression, respectively. Neither the inactivation time constant nor
the time to peak for Ito1 were different among the three groups or between the individual groups (results not shown).
There was also no change in the recovery from inactivation for
Ito1 between control and Reg day 0 groups when assessed by a low stimulation frequency (0.05 Hz,
results not shown).
|
Typical INa/Ca recordings obtained in control
and Reg RV myocytes using the following protocol are illustrated in
Fig. 7, A-C. From a
holding potential of 80 mV, a depolarization to 50 mV was applied
for 20 ms to inactivate the TTX-sensitive transient sodium current.
This was followed by a depolarization to +10 mV for 30 ms to activate
the L-type calcium current. This protocol was applied at 0.1 Hz until
the L-type calcium current and the slow tail inward current recorded on
repolarization to 80 mV reached a steady state (7). The
sodium control solution surrounding the myocyte was then replaced in
5 s with a lithium solution. The lithium-sensitive slow tail
currents shown in Fig. 7, A-C (which can be attributed
to the Na/Ca exchange mechanism), were obtained by subtraction of the
current in the presence of sodium from that after 30 s in the
presence of lithium. Figure 7D shows mean current density of
the lithium-sensitive slow tail current measured 20 ms after the onset
of the repolarization to 80 mV. As previously shown (7),
significant differences in mean lithium-sensitive current densities
between control and Reg myocytes were observed only at day
0. At day 0, this difference was 42.5%, and only 6% and 0% at 20 and 40 days of regression, respectively. The amount of
charges transported by the exchanger at 80 mV was determined by the
integral of the tail current between 9 and 130 ms after the start of
repolarization. The charges moved were as follows: day 0 group, 0.019 ± 0.004 (n = 10) and 0.038 ± 0.002 pC/pF (n = 9, P < 0.05);
day 20 group, 0.023 ± 0.004 (n = 9)
and 0.019 ± 0.004 pC/pF (n = 8, P > 0.05); and day 40 group, 0.025 ± 0.001 (n = 10) and 0.021 ± 0.003 pC/pF
(n = 12, P > 0.05) in the control and
Reg groups, respectively.
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
The present work clearly demonstrates normalization of morphological and electrophysiological changes induced by permanent high-altitude exposure (4,500 m, 20 days) in the adult rat heart after removal of the animals from the hypoxic atmosphere for a sufficiently long period of time. Nevertheless, regression of morphological abnormalities appears to be slower than the regression of electrophysiological changes. As evidenced by both the RV weight-to-heart weight ratio and by the RV free wall thickness measurement (Fig. 2), the RVH induced by permanent simulated high-altitude exposure (4, 5, 7) was still significant at 20 days but no more at 40 days after exposure. The only data regarding regression of altitude-induced cardiac hypertrophy in rats come from intermittent high-altitude exposure (4-8 h/day, 5 or 6 days/week, stepwise up to 7,000 m, 24 exposures). Reported results vary from 2 to 4 wk (14, 22). Regression of heart weight to control values in our model is longer than these latter ones. The reason for these differences in the rate of reversibility is not clear. However, a possible explanation for some of this variability may be the differences in the inciting stimulus (intermittent vs. permanent exposure, duration of the exposure, degree of hypoxia). Regardless of the cause(s) of the variability, the return of heart weight to control values in our model was not a result of changes in water content, because no alteration was found in the ratio of the dry weight to wet weight (data not shown). Some of the hypertrophy reported in this study appears to originate from increased collagen (Fig. 4). Collagen is a very important determinant of myocardial stiffness (type I and III being the major constituants of the extracellular matrix network). Its accumulation in hypertrophic hearts is expected to increase stiffness and affect cardiac function. Indeed, the total collagenic mass was increased by ~26% in the hypertrophied RV but also by ~13% (result not shown) in the LV, which is not hypertrophied in this model (5). The increase in collagen content in both ventricles when only the RV has been stressed is not specific to the permanent high-altitude hypoxia exposure model and has been reported in the model of RVH induced by chronic constriction of the main pulmonary artery in the cat (1) or by intermittent high-altitude hypoxia exposure in the rat (17). In this latter model, the increase in collagen content was 153% and 228% of control values in the RV and LV, respectively. The discrepancy between the two models may result from the difference in the simulated altitude used (intermittent altitude model 7,000 m vs. permanent altitude model 4,500 m) and thus to the higher deleterious degree of hypoxia in the intermittent altitude model. In fact, depending of the experimental model of hypertrophy production, either the LV or RV is principally concerned with a notable enlargment and fibrosis, but the numerous available data in the field proved that the ventricular myocardium was slightly affected in a global manner by a development of fibrous septa, perivascular fibrosis, and intercardiomyocyte collagenic thickening (16, 24). It has been shown that intermittent altitude exposures to 7,000 m can induce focal necrosis in both the RV and LV wall at a time when RVH, but not LVH, was present (27). We have never seen focal necrosis in the myocardium from rats exposed permanently to 4,500 m. These previous and present results corroborate the hypothesis that factors governing connective tissue proliferation may be independent from those governing the cardiomyocyte hypertrophy (12). The regression of collagen content toward the control value in the RV (Fig. 4) appears to parallel the recovery of some RV myocyte parameters (perimeter, capacitance, and width; Fig. 3). Nevertheless, it must be noticed that in the LV a persistent fibrosis was observed even 40 days after the end of altitude exposure (result not shown). Persistent fibrosis, particularly in the LV (17), has already been observed after regression of cardiac hypertrophy and could be due to a slower turnover of fibrillar collagen compared with myofibrillar proteins (6).
The most consistent electrical abnormality that has been described in
association with cardiac hypertrophy is prolongation of the APD
(9). In rat hearts, the ventricular action potential recorded at room temperature in either cardiac tissue (13)
or isolated cardiomyocytes (4, 10) displays two distinct
plateau phases: an early "high" plateau at positive potentials
followed by the onset and slow decay of a "low" plateau, which
occurs at potentials negative to 40 mV. We have previously shown,
with chronic high-altitude hypoxia-induced RVH in the rat, that the decrease in Ito1 and the increase in
INa/Ca densities account for the lengthening of
the high plateau and low plateau of the action potential, respectively
(4, 7). Concerning L-type calcium current density, we
reported a small but significant reduction for potential positive to
+10 mV (4), a change that goes in the wrong direction to
contribute to action potential, and consequently we did not study this
current in our work. Our results show normalization of APD 20 days after the end of altitude exposure (Fig. 5) at a time where
ventricular myocyte hypertrophy was still significant (see above).
Moreover, our results show that in control myocytes the APD had a
tendency to increase from day 0 to day 40 even if this increase was significant only between APD25 at
day 0 and day 40. Such a result, qualitatively
similar to those reported in the rat atrium and attributed to an
age-dependent prolongation (3), could possibly be
explained by a decrease in the density of Ito1
during this period (see below). Previous studies used surgical
(2, 18) or pharmacological methods (19, 20, 28) to produce regression of hypertrophy and reported a
concomitant normalization of ventricular APD. It was then hypothesized
that any intervention that produces regression of hypertrophy restores ventricular electrophysiology, that is to say that the regression of
hypertrophy is responsible for the normalization of
electrophysiological parameters (19). Data obtained from
the chronic high-altitude hypoxia model are in conflict with this
hypothesis. Futhermore, normalization of APD was associated with
normalization of Ito1 density and
INa/Ca density (Figs. 6 and 7). Recently,
molecular and biochemical techniques have been applied to address the
mechanism underlying the reduced potassium current density in cardiac
hypertrophy (for a review, see Ref. 26). This study shows
that compensated hypertrophy after myocardial infarction in the rat is
associated with a decrease in the transcription of Kv4.2 and
Kv4.3, the probable molecular correlates of Ito1
in the adult rat, whereas Kv1.4, the fetal and neonatal rat potassium
channel gene, appears to be reexpressed. Further studies are needed to
see whether the Kv4.2/Kv4.3 to Kv1.4 isoform switch is a general
feature during the cardiac hypertrophy phase whatever the experimental
model used and whether the reverse one takes place during the
regression phase. Because of the fact that Ito1
is one of the major currents involved in the control of the duration of
the rat ventricular action potential, it is tempting to involve it in
the prolongation of action potential seen in the control rat (see
above) even if we report no significant differences between the
Ito1 densities measured in control myocytes at
0, 20, and 40 days (Fig. 6D). Figure
8 shows the evolution of the
Ito1 density measured at +50 mV (open squares)
as a function of age in RV control myocytes. We can see that the
Ito1 density increased from 21 days
postparturition to 2 mo, reached a maximum, and then decreased until 18 mo. These results are qualitatively similar to those reported
previously on neonatal rat ventricular myocytes (21a) and in LV
myocytes isolated from 3- and 18-mo-old normotensive rats (3a). The
mean densities of Ito1 measured at +50 mV (solid
circles) in control myocytes at days 0, 20, and 40 of Fig.
6D are reported in Fig. 8. We can see that these points fit
very well with the curve and thus give substance to a possible role of
Ito1 in the age-dependent prolongation of action
potentials described in control myocytes.
|
We have previously suggested that the increase in the INa/Ca density in hypertrophied ventricular myocytes by chronic high-altitude exposure could be linked to a modification of intracellular calcium homeostasis (7). The normalization of the INa/Ca density 20 days after the end of altitude exposure suggests that the underlying mechanism(s) is plastic and coroborates the previous results of Kolar and Ostadal (14), which showed a normalization of RV contractility within 35 days after the termination of the hypoxic stimulus.
In conclusion, we have shown that reversal of electrophysiological changes observed at the end of a permanent high-altitude exposure (4,500 m, 20 days) seems to take place before the reversal of morphological changes. This differential normalization in chronic hypobaric high-altitude hypoxia is in contrast with the concomitant normalization recorded in animal models of LVH (2, 18-20).
| |
ACKNOWLEDGEMENTS |
|---|
We thank J. Diez for the preparation of the animals.
| |
FOOTNOTES |
|---|
10.1152/ajpheart.00286.2001
This study was supported by the Centre National de la Recherche Scientifique and by a grant from the Région Rhône-Alpes (Programme "Emergence 1997").
Address for reprint requests and other correspondence: R. Bonvallet, UMR CNRS 5123, Physiologie des Régulations Energétiques, Cellulaires et Moléculaires, Université Lyon I, Campus La Doua, 69622 Villeurbanne, France (E-mail: Robert.Bonvallet{at}univ-lyon1.fr).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 30 May 2001; accepted in final form 29 November 2001.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Buccino, RA,
Harris E,
Spann JF,
and
Sonnenblick EH.
Response of myocardial connective tissue to development of experimental hypertrophy.
Am J Physiol
216:
425-428,
1969.
2.
Capasso, JM,
Aronson RS,
and
Sonnenblick EH.
Reversible alterations in excitation-contraction coupling during myocardial hypertrophy in rat papillary muscle.
Circ Res
51:
189-195,
1982
3.
Cavato, FV,
Kelliher GJ,
and
Roberts J.
Electrophysiological changes in the rat atrium with age.
Am J Physiol
226:
1293-1297,
1974.
3a.
Cerbai, E,
Barbieri M,
Li Q,
and
Mugelli A.
Ionic basis of action potential prolongation of hypertrophied cardiac myocytes isolated from hypertensive rats of different ages.
Cardiovasc Res
28:
1180-1187,
1994
4.
Chouabe, C,
Espinosa L,
Megas P,
Chakir A,
Rougier O,
Freminet A,
and
Bonvallet R.
Reduction of ICa,L and Ito1 density in hypertrophied right ventricular cells by simulated high altitude in adult rats.
J Mol Cell Cardiol
29:
193-206,
1997[ISI][Medline].
5.
Chouabe, C,
Megas P,
Chakir A,
Rougier O,
Freminet A,
and
Bonvallet R.
Electrophysiological changes associated with right ventricular hypertrophy induced in adult rat exposed to simulated high altitude.
Gen Physiol Biophys
13:
64-68,
1994.
6.
Eghbali, M,
and
Weber KT.
Collagen and the myocardium: fibrillar structure, biosynthesis, and degradation in relation to hypertrophy and its regression.
Mol Cell Biochem
96:
1-14,
1990[ISI][Medline].
7.
Espinosa, L,
Chouabe C,
Morales A,
Lachuer J,
Georges B,
Fatemi M,
Terrenoire C,
Tourneur Y,
and
Bonvallet R.
Increased sodium-calcium exchange current in right ventricular cell hypertrophy induced by simulated high altitude in adult rats.
J Mol Cell Cardiol
32:
639-653,
2000[ISI][Medline].
8.
Hamill, OP,
Marty A,
Neher E,
Sakmann B,
and
Sigworth FJ.
Improved patch-clamp technique for high-resolution current recording from cells and cell-free membrane patches.
Pflügers Arch
391:
85-100,
1981[ISI][Medline].
9.
Hart, G.
Cellular electrophysiology in cardiac hypertrophy and failure.
Cardiovasc Res
28:
933-946,
1994
10.
Josephson, IR,
Sanchez-Chapula J,
and
Brown AM.
A comparison of calcium currents in rat and guinea pig single ventricular cells.
Circ Res
54:
144-156,
1984
11.
Kolar, F,
and
Ostadal B.
Right ventricular function in rats with hypoxic pulmonary hypertension.
Pflügers Arch
419:
121-126,
1991[ISI][Medline].
12.
Lund, DD,
Twietmeyer TA,
Schmid PG,
and
Tomanek RJ.
Independent changes in cardiac muscle fibres and connective tissue in rats with spontaneous hypertension, aortic constriction and hypoxia.
Cardiovasc Res
13:
39-44,
1979[ISI][Medline].
13.
Momtaz, A,
Coulombe A,
Richer P,
Mercadier JJ,
and
Coraboeuf E.
Action potential and plateau ionic currents in moderately and severely DOCA-salt hypertrophied rat hearts.
J Mol Cell Cardiol
28:
2511-2522,
1996[ISI][Medline].
14.
Ostadal, B,
Kolar F,
Pelouch V,
Prochazka J,
and
Widimsky J.
Intermittent high altitude and the cardiopulmonary system.
In: The Adapted Heart, edited by Nagano M.. Raven, 1994, p. 173-182.
15.
Ostadal, B,
Ostadalova I,
Kolar F,
Pelouch V,
and
Dhalla NS.
Cardiac adaptation to chronic hypoxia.
Adv Organ Biol
6:
43-60,
1998.
16.
Pelouch, V,
Dixon IMC,
Golfman L,
Beamisch RE,
and
Dhalla NS.
Role of extracellular matrix proteins in heart functions.
Mol Cell Biochem
129:
101-120,
1994.
17.
Pelouch, V,
Kolar F,
Ostadal B,
Milerova M,
and
Cihak Widimsky J.
Regression of chronic hypoxia-induced pulmonary hypertension, right ventricular hypertrophy, and fibrosis: effect of enalapril.
Cardiovasc Drugs Ther
11:
177-185,
1997[ISI][Medline].
18.
Rials, SJ,
Wu Y,
Ford N,
Pauletto FJ,
Abramson SV,
Rubin AM,
Marinchak RA,
and
Kowey PR.
Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart.
Circulation
91:
426-430,
1995
19.
Rials, SJ,
Wu Y,
Xu X,
Filart RA,
Marinchak RA,
and
Kowey PR.
Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation.
Circulation
96:
1330-1336,
1997
20.
Rials, SJ,
Xu X,
Wu Y,
Marinchak RA,
and
Kowey PR.
Regression of LV hypertrophy with captopril normalizes membrane currents in rabbits.
Am J Physiol Heart Circ Physiol
275:
H1216-H1224,
1998
21.
Sheedy, W,
Thompson JS,
and
Morice AH.
A comparison of pathophysiological changes during hypobaric and normobaric hypoxia in rats.
Respiration
63:
217-222,
1996[ISI][Medline].
21a.
Shimoni, Y,
Fiset C,
Clark RB,
Dixon JE,
McKinnon D,
and
Giles WR.
Thyroid hormone regulates postnatal expression of transient K+ channel isoforms in rat ventricle.
J Physiol (Lond)
500:
65-73,
1997[ISI][Medline].
22.
Sizemore, DA,
McIntyre TW,
Van Liere EJ,
and
Wilson MF.
Regression of altitude-produced cardiac hypertrophy.
J Appl Physiol
35:
518-521,
1973
23.
Spann, JF,
Buccino RA,
and
Sonnenblick EH.
Production of right ventricular hypertrophy with and without congestive heart failure in the cat.
Proc Soc Exp Biol Med
125:
522-524,
1967[Medline].
24.
Swann, HJ.
Left ventricular dysfunction in ischemic heart disease: fundamental importance of the fibrous matrix.
Cardiovasc Drugs Ther
8:
2305-2312,
1994.
25.
Tucker, A,
McMurtry IF,
Reeves JT,
Alexander AF,
Will DH,
and
Grover RF.
Lung vascular smooth muscle as a determinant of pulmonary hypertension at high altitude.
Am J Physiol
228:
762-767,
1975.
26.
Wickenden, AD,
Kaprielian R,
Kassiri Z,
Tsoporis JN,
Tsushima R,
Fishman GI,
and
Backx PH.
The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure.
Cardiovasc Res
37:
312-323,
1998
27.
Widimsky, J,
Urbanova D,
Ressl J,
Ostadal B,
Pelouch V,
and
Prochazka J.
Effect of intermittent altitude hypoxia on the myocardium and lesser circulation in the rat.
Cardiovasc Res
7:
798-808,
1973[ISI][Medline].
28.
Yokoshiki, H,
Kohya T,
Tomita F,
Tohse N,
Nakaya H,
Kanno M,
and
Kitabatake A.
Restoration of action potential duration and transient outward current by regression of left ventricular hypertrophy.
J Mol Cell Cardiol
29:
1331-1339,
1997[ISI][Medline].
This article has been cited by other articles:
|
|
 |
|
  C. Chouabe, E. Ricci, J. Amsellem, S. Blaineau, Y. Dalmaz, R. Favier, J.-M. Pequignot, and R. Bonvallet Effects of aging on the cardiac remodeling induced by chronic high-altitude hypoxia in rat Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1246 - H1253. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
) represents the
average of 14-20 myocytes. The current was elicited by a 600-ms
depolarizing pulse to +50 mV applied every 10 s from a holding
potential of 
, mean densities of Ito1
measured at +50 mV in control myocytes at days 0,
20, and 40 as shown in Fig.